The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Kite, a Gilead company
Speakers' Bureau - Jazz Pharmaceuticals; Kite, a Gilead company
Research Funding - Amgen
A phase 4 study to evaluate outpatient blinatumomab in patients with minimal/measurable residual disease (MRD) positivity (+) of B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
 
Sharif S. Khan
No Relationships to Disclose
 
Shahram Mori
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
 
Deepa Jeyakumar
Research Funding - Jazz Pharmaceuticals; Pfizer
 
Michael Kenneth Keng
Consulting or Advisory Role - Agios
 
Hemant S. Murthy
Research Funding - crispr therapeutics (Inst)
 
Michal Bar-Natan
Research Funding - Celgene (Inst); Incyte (Inst)
Travel, Accommodations, Expenses - Merus
 
Krishna Gundabolu
Stock and Other Ownership Interests - Geron
Consulting or Advisory Role - Biomarin; Bristol-Myers Squibb Company; Jazz Pharmaceuticals; Novartis; Pfizer
Travel, Accommodations, Expenses - Biomarin; Jazz Pharmaceuticals
 
Kristen M. O'Dwyer
No Relationships to Disclose
 
Tulio Rodriguez
No Relationships to Disclose
 
Anthony Selwyn Stein
Consulting or Advisory Role - Amgen; Stemline Therapeutics
Speakers' Bureau - Amgen; Stemline Therapeutics
 
Wendy Stock
Honoraria - Abbvie
Consulting or Advisory Role - Adaptive Biotechnologies; agios; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Kura Oncology; morphosys; Pfizer; SERVIER
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Caspian Oliai
No Relationships to Disclose
 
Christopher McCann
Employment - Current Health
Leadership - Current Health
Stock and Other Ownership Interests - Current Health
 
Faraz Zaman
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Gerhard Zugmaier
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Multiple patents
 
Paul Gordon
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Timothy S. Pardee
Consulting or Advisory Role - Abbvie; Genentech; Rafael Pharmaceuticals
Speakers' Bureau - Amgen; Celgene; Novartis; Pharmacyclics
Research Funding - Karyopharm Therapeutics; Rafael Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Named on a provisional patent on the use of KPC34 for the treatment of acute leukemias.
Travel, Accommodations, Expenses - Pharmacyclics; Rafael Pharmaceuticals